comparemela.com

Latest Breaking News On - Biopharmaceutical co ltd - Page 1 : comparemela.com

Top 10 Best Unicorns In Iceland

Xuanzhu Biopharm nabs $96m and 58 more deal updates worth over $2b

Xuanzhu Biopharm nabs $96m and 58 more deal updates worth over $2b
dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.

Regency Centers Invites You to Join Its Fourth Quarter 2020 Earnings Conference Call

Regency Centers Invites You to Join Its Fourth Quarter 2020 Earnings Conference Call Regency Centers Invites You to Join Its Fourth Quarter 2020 Earnings Conference Call JACKSONVILLE, Fla., Dec. 16, 2020 Regency Centers Corporation (The “Company”) (NASDAQ: REG) will announce its Fourth Quarter 2020 earnings results on Thursday, February 11, 2021, after the market closes. The Company’s earnings release and supplemental information package will be posted on the Investor Relations section of the Company’s website – investors.regencycenters.com. The Company will host an earnings conference call on Friday, February 12, 2021, at 12:00 p.m. ET. Fourth Quarter 2020 Earnings Conference Call Date: About Regency Centers Corporation (NASDAQ: REG)

dMed Completed a US$100 Million Series C Financing

dMed Completed a US$100 Million Series C Financing News provided by Share this article Share this article SHANGHAI, Dec. 17, 2020 /PRNewswire/ dMed, the clinical CRO with strong presence in China and the US, the world s two largest pharmaceutical markets and drug development sites, announced today its successful completion of a US$100 million Series C financing. Led by Fidelity Management & Research Company, LLC, new investors in dMed include Sequoia Capital China, Kaiser Foundation Hospitals and E Fund. They now join the leaders in dMed s angel, A and B rounds, Qiming Venture Partners, Lilly Asia Ventures, and Vivo Capital, which have taken most of the opportunities to increase their contributions to dMed s capital since the company s inception in 2016.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.